Newsletter Subject

Announcing 📣 NEW Matching Gift Challenge

From

alz.org

Email Address

info@alz.org

Sent On

Thu, Aug 3, 2023 11:22 AM

Email Preheader Text

Our NEW $600,000 Matching Gift Challenge starts today. Dear Friend, Alzheimer's disease is a thief.

Our NEW $600,000 Matching Gift Challenge starts today. [Alzheimer's Association]( [DONATE NOW]( [$600,000 Matching Gift Challenge]( Dear Friend, Alzheimer's disease is a thief. It steals memories, independence and, ultimately, life. But hope is on the horizon. The Food and Drug Administration (FDA) has now approved two treatments that reduce cognitive and functional decline for those living with early Alzheimer's. These are the first wave of effective treatments for Alzheimer's that can slow cognitive and functional decline for some people living with early Alzheimer's. We're fighting to ensure access for everyone who could benefit from these treatments — and your support is crucial. While this is a tremendous step forward, the Alzheimer's Association's work is far from done. We won't rest until everyone living with Alzheimer's — at any stage — can get the treatment, care and support they need and deserve. That's why I'm excited to announce a [special, new opportunity for you to double your impact in the fight to end Alzheimer's](. Longtime supporters and Alzheimer's Association Zenith Society members, Dick and Marianne Kipper, have pledged to match every donation we receive by September 30 — up to a total of $600,000 to support Alzheimer's research — if we can raise the same amount by the deadline. [This means, by making your first gift today to our $600,000 Matching Gift Challenge, your support can go TWICE as far.]( Join our $600,000 Matching Gift Challenge and see how far your gift can go. [$16 can become $32.]( [$30 can become $60.]( [$50 can become $100.]( [Double my impact now.]( With the Kippers' matching gift and your generous donation today, your support can go twice as far to help provide care and support and accelerate research — that can lead to breakthrough treatments. This July, the FDA granted traditional approval of lecanemab (Leqembi®) for the treatment of early Alzheimer's disease. This is the first Alzheimer's treatment granted traditional approval that can change the underlying course of the disease. Each new breakthrough brings hope to individuals coping with this disease, which is why we won't stop until there is a cure. Today, more than 6 million Americans are living with Alzheimer's — and 1 in 3 seniors will die with this terrible disease. The impact on lives, families and loved ones is devastating. [With your support — which can be matched today to go 2X as far — we can turn the tide.]( There couldn't be a more ideal time to join our community of supporters. [Donate Now]( With your help, the Alzheimer's Association pushes forward in our mission to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. [Your first gift can be matched today and can help us continue to:]( - Identify treatment strategies in an increasingly robust treatment pipeline, including combining diverse approaches into combination therapies — because more treatments that target the disease from all angles are needed. - Increase public understanding of Alzheimer's disease by helping families across the nation realize the importance of early detection and the benefits it can have on their lives with the advent of these new treatments. - Improve care and support for people living with dementia, as well as for their families, and ensure the voices of people with Alzheimer's are heard. - Further our knowledge about ongoing studies to address brain health and disease prevention through studies such as our landmark U.S. POINTER clinical trial designed to evaluate how interventions that simultaneously target multiple risk factors may protect cognitive function in older adults who are at increased risk for cognitive decline. Friend, this [$600,000 Matching Gift Challenge]( BEGINS NOW. Will you help us get off to a strong start with your first gift today? [Donate Now]( Every dollar raised during this limited-time challenge — up to $600,000 — can be matched to go twice as far in the fight against this thief of a disease. Thank you. Sincerely, Donna McCullough Chief Mission and Field Operations Officer [Facebook]( [Twitter]( P.S. [Please make your first gift now while you can double your impact and help us achieve our vision of a world without Alzheimer's and other dementia.]( Your donation will strengthen our efforts to advance Alzheimer's care, support and research. From face-to-face support to online education programs and promising global research initiatives, your gift makes a difference in the lives of all those affected by Alzheimer's and other dementias in your community and across the world. Thank you for your continued support. Alzheimer's Association Home Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 © 2023 Alzheimer's Association. All rights reserved. 800.272.3900 | [alz.org]( | [Donate]( Please add info@alz.org to your address book to ensure you receive all future emails. Having trouble reading this email? [View it in your browser]( [View your email preferences or unsubscribe](. [(

alz.org

Donna McCullough, Alzheimer's Association

Marketing emails from alz.org

View More
Sent On

11/04/2024

Sent On

11/04/2024

Sent On

10/04/2024

Sent On

09/04/2024

Sent On

09/04/2024

Sent On

08/04/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.